Cargando…
2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases
Premature termination codons (PTCs) account for 10 to 20% of genetic diseases in humans. The gene inactivation resulting from PTCs can be counteracted by the use of drugs stimulating PTC readthrough, thereby restoring production of the full-length protein. However, a greater chemical variety of read...
Autores principales: | Bidou, Laure, Bugaud, Olivier, Merer, Goulven, Coupet, Matthieu, Hatin, Isabelle, Chirkin, Egor, Karri, Sabrina, Demais, Stéphane, François, Pauline, Cintrat, Jean-Christophe, Namy, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436315/ https://www.ncbi.nlm.nih.gov/pubmed/35994666 http://dx.doi.org/10.1073/pnas.2122004119 |
Ejemplares similares
-
Statistical Analysis of Readthrough Levels for Nonsense Mutations in Mammalian Cells Reveals a Major Determinant of Response to Gentamicin
por: Floquet, Célia, et al.
Publicado: (2012) -
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
por: Pranke, Iwona, et al.
Publicado: (2018) -
Increased expression of tryptophan and tyrosine tRNAs elevates stop codon readthrough of reporter systems in human cell lines
por: Beznosková, Petra, et al.
Publicado: (2021) -
Identification of stop codon readthrough genes in Saccharomyces cerevisiae
por: Namy, Olivier, et al.
Publicado: (2003) -
Nonaminoglycoside compounds induce readthrough of nonsense mutations
por: Du, Liutao, et al.
Publicado: (2009)